Quantitative Proteomic Analysis of Proteins Released by Neoplastic Prostate Epithelium

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Research

• Publication date

  2004-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-03-2062PMID 14729644
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Notch and the amyloid precursor protein are cleaved by similar gamma-secretase(s).

  2003cited by this paper
• A statistical model for identifying proteins by tandem mass spectrometry.

  2003influential reference
• Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors.

  2003cited by this paper
• Reprints and Subscriptions Permissions

  2003cited by this paper
• The Application of New Software Tools to Quantitative Protein Profiling Via Isotope-coded Affinity Tag (ICAT) and Tandem Mass Spectrometry

  2003cited by this paper
• Cancer Statistics, 2003

  2003cited by this paper
• The Application of New Software Tools to Quantitative Protein Profiling Via Isotope-coded Affinity Tag (ICAT) and Tandem Mass Spectrometry

  2003cited by this paper
• The Notch Ligands, Delta1 and Jagged2, Are Substrates for Presenilin-dependent “γ-Secretase” Cleavage*

  2003cited by this paper
• Automated statistical analysis of protein abundance ratios from data generated by stable-isotope dilution and tandem mass spectrometry.

  2003influential reference
• Proteomic analysis of human prostate cancer †

  2002cited by this paper
• Quantitative Protein Profiling Using Two-dimensional Gel Electrophoresis, Isotope-coded Affinity Tag Labeling, and Mass Spectrometry*

  2002cited by this paper
• Screening for Prostate Cancer: Recommendation and Rationale

  2002cited by this paper
• VEGF and the quest for tumour angiogenesis factors

  2002cited by this paper
• Processing of beta-amyloid precursor-like protein-1 and -2 by gamma-secretase regulates transcription.

  2002cited by this paper
• Analysis of microdissected prostate tissue with ProteinChip arrays--a way to new insights into carcinogenesis and to diagnostic tools.

  2002cited by this paper
• Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells

  2002cited by this paper
• γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in?

  2002cited by this paper
• gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?

  2002cited by this paper
• Shedding light on sheddases: role in growth and development.

  2002cited by this paper
• Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer

  2002cited by this paper
• Processing of β-Amyloid Precursor-like Protein-1 and -2 by γ-Secretase Regulates Transcription*

  2002cited by this paper
• Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

  2002cited by this paper
• A Proteomic Approach for the Identification of Cell-surface Proteins Shed by Metalloproteases*

  2002cited by this paper
• Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

  2002cited by this paper
• Serum proteomic patterns for detection of prostate cancer.

  2002cited by this paper
• Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.

  2002cited by this paper
• Androgens modulate the balance between VEGF and angiopoietin expression in prostate epithelial and smooth muscle cells

  2002cited by this paper
• A presenilin‐1/γ‐secretase cleavage releases the E‐cadherin intracellular domain and regulates disassembly of adherens junctions

  2002influential reference
• Optimization of the isotope-coded affinity tag-labeling procedure for quantitative proteome analysis.

  2001cited by this paper
• A role for membrane-type serine protease (MT-SP1) in intestinal epithelial turnover.

  2001cited by this paper
• Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry

  2001cited by this paper
• Advances in Proteome Analysis by Mass Spectrometry*

  2001cited by this paper
• Advances in proteome analysis by mass spectrometry.

  2001cited by this paper
• Mass spectrometry in proteomics.

  2001cited by this paper
• Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry

  2001cited by this paper
• American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer Detection

  2001cited by this paper
• Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts.

  2001cited by this paper
• Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway.

  2001cited by this paper
• Large-scale analysis of the yeast proteome by multidimensional protein identification technology

  2001cited by this paper
• Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.

  2001cited by this paper
• Identification of androgen‐regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis

  2001cited by this paper
• Dynamics of notch expression during murine prostate development and tumorigenesis.

  2001cited by this paper
• Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins.

  2000cited by this paper
• Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines

  2000cited by this paper
• Clinical Oncology, 2nd edn

  2000cited by this paper
• Vascular-specific growth factors and blood vessel formation

  2000cited by this paper
• Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1.

  2000cited by this paper
• Comprehensive analyses of prostate gene expression: Convergence of expressed sequence tag databases, transcript profiling and proteomics

  2000cited by this paper
• Polypeptide Expression in Prostate Hyperplasia and Prostate Adenocarcinoma

  2000cited by this paper
• A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE.

  2000cited by this paper
• Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch-1

  2000cited by this paper
• Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology.

  2000cited by this paper
• Regulation of the quiescence-induced genes: quiescin Q6, decorin, and ribosomal protein S29.

  2000influential reference
• Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

  1999cited by this paper
• Large-scale identification of secreted and membrane-associated gene products using DNA microarrays

  1999cited by this paper
• Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats.

  1999cited by this paper
• Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

  1999cited by this paper
• Large-scale identification of secreted and membrane-associated gene products using DNA microarrays

  1999cited by this paper
• Bicalutamide (Casodex)-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins.

  1999cited by this paper
• Protein analysis by mass spectrometry and sequence database searching: Tools for cancer research in the post‐genomic era

  1999cited by this paper
• Purification and Characterization of a Complex Containing Matriptase and a Kunitz-type Serine Protease Inhibitor from Human Milk*

  1999influential reference
• Apoptosis control by death and decoy receptors.

  1999cited by this paper
• Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2,3,4 and 5.

  1998cited by this paper
• Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration

  1998cited by this paper
• Apoptosis signaling by death receptors.

  1998cited by this paper
• Castration-Induced Apoptosis in the Rat Ventral Prostate Is Associated with Increased Expression of Genes Encoding Insulin-Like Growth Factor Binding Proteins 2, 3, 4 and 5.

  1998cited by this paper
• Screening for prostate cancer. American College of Physicians.

  1997cited by this paper
• Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.

  1997cited by this paper
• Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.

  1997cited by this paper
• Hepatocyte Growth Factor Activator Inhibitor, a Novel Kunitz-type Serine Protease Inhibitor*

  1997influential reference
• Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.

  1997cited by this paper
• Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells.

  1997cited by this paper
• Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane.

  1997cited by this paper
• Characterization of a Novel, Membrane-bound, 80-kDa Matrix-degrading Protease from Human Breast Cancer Cells

  1997cited by this paper
• Membrane protein secretases.

  1997cited by this paper
• Tissue specific and androgen-regulated expression of human prostate-specific transglutaminase.

  1996cited by this paper
• Activation of Hepatocyte Growth Factor in the Injured Tissues Is Mediated by Hepatocyte Growth Factor Activator (*)

  1996cited by this paper
• Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate.

  1996influential reference
• Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen.

  1995cited by this paper
• A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor.

  1995cited by this paper
• Amyloid precursor-like protein 2 (APLP2) is modified by the addition of chondroitin sulfate glycosaminoglycan at a single site.

  1994cited by this paper
• A serum‐free defined medium capable of supporting growth of four established human prostatic carcinoma cell lines

  1994cited by this paper
• An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database

  1994influential reference
• Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP

  1993cited by this paper
• Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells.

  1993cited by this paper
• Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients.

  1993influential reference
• LNCaP model of human prostatic carcinoma.

  1983cited by this paper
• The LNCaP cell line--a new model for studies on human prostatic carcinoma.

  1980cited by this paper
• The American College of Physicians

  1968cited by this paper

• Impact of Mammary Tumor Induction on Liver Tissue Proteome.

  2025cites this paper
• Effects of redox modulation on quiescin/sulfhydryl oxidase activity of melanoma cells

  2023cites this paper
• Nuclear and Membrane Receptors for Sex Steroids Are Involved in the Regulation of Delta/Serrate/LAG-2 Proteins in Rodent Sertoli Cells

  2022cites this paper
• Peri/Epicellular Thiol Oxidoreductases as Mediators of Extracellular Redox Signaling

  2020cites this paper
• Chapter 13 Dual Role of METCAM / MUC 18 Expression in the Progression of Cancer Cells

  2019cites this paper
• Proteomics in Prostate Cancer Research

  2018cites this paper
• Dual Role of METCAM/MUC18 Expression in the Progression of Cancer Cells

  2018cites this paper
• Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers

  2018cites this paper
• Electrochemical aptamer-based biosensor developed to monitor PSA and VEGF released by prostate cancer cells

  2017cites this paper
• The Discovery of Cancer Tissue Specific Proteins in Serum: Case Studies on Prostate Cancer

  2017cites this paper
• Chemical glycoproteomics for identification and discovery of glycoprotein alterations in human cancer

  2017cites this paper
• Proteolytic regulation of the EphB4-Ephrin-B2 signalling axis in prostate cancer

  2016cites this paper
• Notch signaling dynamics in the adult healthy prostate and in prostatic tumor development

  2016cites this paper
• Parallel Protein Detection by Solid‐Phase Proximity Ligation Assay with Real‐Time PCR or Sequencing

  2015cites this paper
• Proteomics and Prostate Cancer

  2015cites this paper
• The role of proteomics in colorectal cancer biomarker discovery

  2015cites this paper
• Quantitative proteomics of androgen receptor-mediated signaling networks in prostate tumor cells

  2015cites this paper
• Novel biomarker for prostate cancer diagnosis by MRS.

  2014cites this paper
• Cell Cycle and Senescence Androgen Receptor Promotes the Oncogenic Function of Overexpressed Jagged 1 in Prostate Cancer by Enhancing Cyclin B 1 Expression via Akt Phosphorylation

  2014cites this paper
• Androgen Receptor Promotes the Oncogenic Function of Overexpressed Jagged1 in Prostate Cancer by Enhancing Cyclin B1 Expression via Akt Phosphorylation

  2014cites this paper
• Evaluation of ERG responsive proteome in prostate cancer

  2014cites this paper
• Disulfide bond generation in mammalian blood serum: detection and purification of quiescin-sulfhydryl oxidase.

  2014cites this paper
• Eph receptors and their ligands: promising molecular biomarkers and therapeutic targets in prostate cancer.

  2013cites this paper
• Redox regulation of inflammation and immunity

  2013cites this paper
• Proteomics of human prostate cancer biospecimens: the global, systems-wide perspective for Protein markers with potential clinical utility

  2013cites this paper
• Experimental Models of Prostate Cancer Bone Metastasis - Establishment, characterization and imaging of xenograft bone metastasis models -

  2013cites this paper
• Identification and Validation of Candidate Breast Cancer Biomarkers: A Mass Spectrometric Approach

  2012cites this paper
• Notch signaling pathway and cancer metastasis.

  2012cites this paper
• Antiproliferative mechanisms of action of the flavin dehydrogenase inhibitors diphenylene iodonium and di-2-thienyliodonium based on molecular profiling of the NCI-60 human tumor cell panel.

  2012cites this paper
• Castration-resistant prostate cancer: potential targets and therapies

  2012cites this paper
• iTRAQ Identification of Candidate Serum Biomarkers Associated with Metastatic Progression of Human Prostate Cancer

  2012cites this paper
• Proteomics Tools for Oral Cancer Biomarker Discovery

  2012cites this paper
• Integrative analysis of N-linked human glycoproteomic data sets reveals PTPRF ectodomain as a novel plasma biomarker candidate for prostate cancer.

  2012cites this paper
• Conditioned media from cell lines: A complementary model to clinical specimens for the discovery of disease‐specific biomarkers

  2011cites this paper
• Differential proteome analysis of conditioned medium of BPH-1 and LNCaP cells.

  2011cites this paper
• Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells.

  2011cites this paper
• Biomarkers and Receptor Expression in Neuroendocrine Tumours

  2011cites this paper
• The use of proteomics techniques to identify potential markers of early stage colorectal cancer

  2011cites this paper
• Metabolomic Profiling Reveals a Role for Androgen in Activating Amino Acid Metabolism and Methylation in Prostate Cancer Cells

  2011cites this paper
• Identification of new urine biomarkers for the detection of prostate cancer

  2011cites this paper
• The cancer cell secretome: a good source for discovering biomarkers?

  2010influential citation
• Maspin (SERPINB5) Is an Obligate Intracellular Serpin*

  2010cites this paper
• Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.

  2010cites this paper
• Applications of Proteomics in Prostate Cancer

  2010cites this paper
• Down‐regulation of Notch‐1 and Jagged‐1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF‐κB signaling pathways

  2010cites this paper
• Oxidative Protein Folding and the Quiescin–Sulfhydryl Oxidase Family of Flavoproteins

  2010cites this paper
• Proteomics in prostate cancer biomarker discovery

  2010cites this paper
• Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.

  2010cites this paper
• [Identification and expression of two new secretory proteins associated with prostate cancer].

  2010cites this paper
• ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer

  2010cites this paper
• Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum.

  2010cites this paper
• Secretome proteomics for discovery of cancer biomarkers.

  2010cites this paper
• Advances in proteomic prostate cancer biomarker discovery.

  2010cites this paper
• Prostate cancer proteomics: The urgent need for clinically validated biomarkers

  2009influential citation
• Androgen-Regulated Genes in the Prostate

  2009cites this paper
• Proteomic Interrogation of Androgen Action in Prostate Cancer Cells Reveals Roles of Aminoacyl tRNA Synthetases

  2009cites this paper
• Characterization of de novo synthesized proteins released from human colorectal tumour explants

  2009cites this paper
• Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosis

  2009cites this paper
• Le secretome, un modèle adapté à l'étude des protéines sécrétées par les tumeurs. Application à l'analyse du rôle joué par p53 sur la sécrétion de protéines par des cellules du cancer du poumon.

  2009influential citation
• Cancer and the tumor microenvironment: a review of an essential relationship

  2009cites this paper
• The cell line secretome, a suitable tool for investigating proteins released in vivo by tumors: application to the study of p53-modulated proteins secreted in lung cancer cells.

  2009cites this paper
• Metabolic labeling and protein linearization technology allow the study of proteins secreted by cultured cells in serum-containing media.

  2009cites this paper
• Identification of Five Candidate Lung Cancer Biomarkers by Proteomics Analysis of Conditioned Media of Four Lung Cancer Cell Lines*

  2009cites this paper
• Identification of Mac-2-binding Protein as a Putative Marker of Neuroendocrine Tumors from the Analysis of Cell Line Secretomes*

  2009cites this paper
• Proteomics strategies for target identification and biomarker discovery in cancer.

  2009cites this paper
• Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry.

  2008cites this paper
• Zymogen activation, inhibition, and ectodomain shedding of matriptase.

  2008cites this paper
• Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.

  2008cites this paper
• The mammary epithelial cell secretome and its regulation by signal transduction pathways.

  2008cites this paper
• Notch signaling: a potential therapeutic target in prostate cancer.

  2008cites this paper
• A proteomic approach to the analysis of RNA degradosome composition in Escherichia coli.

  2008cites this paper
• Secretory vesicle analysis for discovery of low abundance plasma biomarkers.

  2008cites this paper
• Proteomics of cancer of hormone-dependent tissues.

  2008cites this paper
• Tissue culture‐based breast cancer biomarker discovery platform

  2008cites this paper
• Aldehyde dehydrogenase 1A1 and gelsolin identified as novel invasion-modulating factors in conditioned medium of pancreatic cancer cells.

  2008cites this paper
• Generating disulfides with the Quiescin-sulfhydryl oxidases.

  2008cites this paper
• [Secretome: definitions and biomedical interest].

  2008cites this paper
• The Notch pathway in prostate development and cancer.

  2008influential citation
• Proteomic analysis of prostate cancer cell line conditioned media for the discovery of candidate biomarkers for prostate cancer.

  2008cites this paper
• Quantitative proteomics in the characterization of T helper lymphocyte differentiation

  2008cites this paper
• QUANTITATIVE PROTEOMICS IN THE CHARACTERIZATION OF T HELPER LYMPHOCYTE DIFFERENTIATION

  2008cites this paper
• Le sécrétome : définitions et intérêt biomédical

  2008cites this paper
• The cancer secretome: a reservoir of biomarkers

  2008cites this paper
• Comparison of Pancreas Juice Proteins from Cancer Versus Pancreatitis Using Quantitative Proteomic Analysis

  2007cites this paper
• Novel biomarkers for cancer detection and prognostication

  2007cites this paper
• Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer.

  2007cites this paper
• Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium.

  2007cites this paper
• Development and validation of a spectral library searching method for peptide identification from MS/MS

  2007cites this paper
• Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Co

  2007cites this paper
• Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells.

  2007cites this paper
• Proteomics Analysis of Conditioned Media from Three Breast Cancer Cell Lines

  2007cites this paper
• High-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery.

  2007cites this paper
• Evaluation of an in vitro model of androgen ablation and identification of the androgen responsive proteome in LNCaP cells

  2007cites this paper
• Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry.

  2007cites this paper
• Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations.

  2007cites this paper
• Integrin-Mediated Signaling in Prostate Cancer: Role of KAI1/CD82 in Regulating Integrin and Androgen Receptor Function During Metastasis

  2007cites this paper
• β-2-Microglobulin Is an Androgen-Regulated Secreted Protein Elevated in Serum of Patients with Advanced Prostate Cancer

  2007cites this paper
• Anwendung der SELDI-TOF-Massenspektrometrie zur Identifizierung neuer Biomarker: Möglichkeiten und Grenzen / Application of SELDI-TOF-mass spectrometry for biomarker identification: potentials and limitations

  2007cites this paper
• Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Comp

  2007cites this paper
• Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes.

  2007cites this paper